CYTO Altamira Therapeutics
- 1.4500
- +0.0100+0.69%
Altamira Therapeutics News
Altamira Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Altamira Therapeutics | F-1: Registration statement for securities of certain foreign private issuers
Altamira Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | F-1/A: Registration statement for securities of certain Canadian issuers (Amendment)
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | F-1: Registration statement for securities of certain foreign private issuers
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Altamira Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers
Altamira Therapeutics | F-1: Registration statement for securities of certain foreign private issuers
Altamira Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
